We further performed both in vitro and vivo experiments to investigate the effects of PLOD1 on GSCs proliferation, invasion, anti-apoptosis, and MES transition in GBM under hypoxic conditions, demonstrating that PLOD1 can be a potential therapeutic target for GBM, especially mesenchymal GBM. This evidence concerns the gene PLOD1 and glioblastoma.